Taken together with the results of the tumor immune evaluation (Fig. 6), PPA@aPD-L1 remolded the intratumoral immunosuppressive microenvironment by inhibiting the NF-κB and STAT3 pathways in tumor cells. Here, STAT3 is linked to neoplasm.